<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Pharmacol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Indian J Pharmacol</journal-id>
      <journal-id journal-id-type="publisher-id">IJPharm</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Pharmacology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0253-7613</issn>
      <issn pub-type="epub">1998-3751</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25538340</article-id>
      <article-id pub-id-type="pmc">4264084</article-id>
      <article-id pub-id-type="publisher-id">IJPharm-46-651</article-id>
      <article-id pub-id-type="doi">10.4103/0253-7613.144941</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Drug Watch</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hypoglycemia - A rare complication of carbamazepine overdose</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jha</surname>
            <given-names>Avanish</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abhilash</surname>
            <given-names>Kundavaram Paul Prabhakar</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bandhyopadhyay</surname>
            <given-names>Rini</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Victor</surname>
            <given-names>Peter John</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Medical Intensive Care Unit, Christian Medical College, Vellore, Tamil Nadu, India</aff>
      <aff id="aff2"><label>1</label>Department of General Medicine, Christian Medical College, Vellore, Tamil Nadu, India</aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence to:</bold> Dr. Kundavaram Paul Prabhakar Abhilash, E-mail: <email xlink:href="kppabhilash@gmail.com">kppabhilash@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2014</year>
      </pub-date>
      <volume>46</volume>
      <issue>6</issue>
      <fpage>651</fpage>
      <lpage>652</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>3</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>24</day>
          <month>5</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>7</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Indian Journal of Pharmacology</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Carbamazepine overdose usually presents with neurological manifestations such as ataxia, seizures and altered sensorium or cardiac manifestations that include tachycardia, hypotension and ventricular extra-systoles. We report a patient with carbamazepine overdose who manifested recurrent hypoglycemia on the third and fourth day following ingestion that resolved with supportive therapy.</p>
      </abstract>
      <kwd-group>
        <title>KEY WORDS</title>
        <kwd>Anti-epileptic</kwd>
        <kwd>carbamazepine</kwd>
        <kwd>complication</kwd>
        <kwd>hypoglycemia</kwd>
        <kwd>overdose</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-1">
      <title>Introduction</title>
      <p>Carbamazepine, a first line antiepileptic belonging to the iminostilbene group, contributes to 46.9% of antiepileptic drug overdose in the United Kingdom.[<xref rid="ref1" ref-type="bibr">1</xref>] Overdose results in neurologic, cardiac and metabolic manifestations.[<xref rid="ref1" ref-type="bibr">1</xref>] We report the occurrence of recurrent and protracted hypoglycemia in the setting of carbamazepine overdose.</p>
    </sec>
    <sec id="sec1-2">
      <title>Case Report</title>
      <p>A 20-year-old pregnant woman at 26-weeks of gestation, on anti-epileptic therapy with carbamazepine presented with a history of consumption of 4000 mg (200 mg &#xD7; 20 tablets) of carbamazepine. She denied concomitant overdose with other medications. Following gastric lavage at a local hospital, she was transferred to our hospital 4-hours after ingestion. At presentation Glasgow coma score (GCS) was 3/15, pulse rate was 138/min, blood pressure 110/70 mmHg and respiratory rate 25/min. Capillary blood glucose level was 109 mg/dl. Pupils were dilated 6 mm bilaterally and reacting to light. Deep tendon reflexes were sluggish and Babinski sign was negative. Rest of systemic examination was unremarkable. She was intubated for low sensorium. Multi-dose activated charcoal therapy (50 grams every 6 hours) was administered. She was shifted to the intensive care unit (ICU) for ventilation and monitoring.</p>
      <p>Serum carbamazepine level was &gt; 20 &#x3BC;g/ml (therapeutic level 6-12 &#x3BC;g/ml). Hemoglobin was 8 g/dl and white count 15,200/cumm. Renal function, liver function test and coagulation profile were within normal limits. Six hours into admission she developed circulatory shock requiring fluid resuscitation and low dose vasopressors. Empiric antibiotic therapy was initiated, which was subsequently discontinued in view of negative cultures, low procalcitonin (0.34) and absence of a definite focus of infection.</p>
      <p>On the third day, several episodes of hypoglycemia were observed [<xref ref-type="fig" rid="F1">Figure 1</xref>] which was managed initially with bolus doses of 50% dextrose for each episode and subsequently with an infusion of 25% dextrose. The infusion was given for 60 hours following which there were no further episodes of hypoglycemia. Other causes of hypoglycemia including drugs, renal or hepatic failure and sepsis were ruled out. Serum carbamazepine level on the third day was still elevated (17.3 &#x3BC;g/ml) and decreased to sub therapeutic range by the seventh day (2.97 &#x3BC;g/ml).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Serial blood glucose levels after carbamazepine overdose</p>
        </caption>
        <graphic xlink:href="IJPharm-46-651-g001"/>
      </fig>
      <p>By day 7, she was extubated and vasoactive agents were weaned. Serum carbamazepine level showed a declining trend and normalized. At 2-months follow-up no further hypoglycemic episodes were documented.</p>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>Discussion</title>
      <p>Carbamazepine a drug used for the treatment of trigeminal neuralgia and epilepsy acts by preventing repeated firing of the neurons by prolonging the inactive state of the sodium channels. The maintenance dose is 15-20 mg/kg. Oral absorption is slow and variable due to poor water solubility. It is highly protein bound (75%) and is metabolized in liver by CYP 3A4. It is an inducer of CYP 3A4 and this auto-induction requires up-scaling of doses in chronic use.</p>
      <p>Carbamazepine may produce rash and photosensitivity but serious idiosyncratic reactions such as drug-induced lupus and agranulocytosis are relatively rare.[<xref rid="ref2" ref-type="bibr">2</xref>] Acute overdose results in neurotoxicity and cardiac collapse. Neurological symptoms include ataxia, nystagmus, seizures, status epilepticus and altered sensorium.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>] Cardiotoxicity manifests as tachycardia, hypotension and ventricular extra systoles.[<xref rid="ref5" ref-type="bibr">5</xref>] Acute hypernatremia, a rare complication of overdose is due to inappropriate anti-diuretic hormone secretion.[<xref rid="ref6" ref-type="bibr">6</xref>] Hepatotoxicity, common with chronic use is rare in acute overdose.[<xref rid="ref7" ref-type="bibr">7</xref>]</p>
      <p>Our patient had neurotoxicity and cardiotoxicity as evidenced by depressed sensorium and prolonged circulatory shock with tachycardia. Recurrent and protracted hypoglycemia, which our patient manifested, has not been reported following overdose. The mechanism of hypoglycemia was unclear. Although valproic acid can cause hyperinsulinemia,[<xref rid="ref8" ref-type="bibr">8</xref>] there is no evidence that carbamazepine impacts insulin levels. Thus possible mechanisms for hypoglycemia include increased insulin secretion, decreased gluconeogenesis, increased glucose utilization and storage or decreased glucagon release. Increased fetal glucose demand may have contributed to hypoglycemia; the absence of hypoglycemic episodes following recovery from the overdose however suggests other mechanism (s) for hypoglycemia. Measurement of plasma insulin levels may have helped in ascertaining the mechanism of hypoglycemia, however this was not done for our patient.</p>
    </sec>
    <sec sec-type="conclusion" id="sec1-4">
      <title>Conclusion</title>
      <p>Hypoglycemiamay be encountered in carbamazepine overdose. Clinicians need to be aware of this complication and monitor blood glucose in those who present with toxicity.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil.</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> No.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nixon</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Doak</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Crozier</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Crooks</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Waring</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
          <article-title>Patterns of antiepileptic drug overdose differ between men and women: Admissions to the Edinburgh Poisons Unit, 2000-2007</article-title>
          <source>QJM</source>
          <year>2009</year>
          <volume>101</volume>
          <fpage>51</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">19004924</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daughton</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Padala</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Gabel</surname>
              <given-names>TL</given-names>
            </name>
          </person-group>
          <article-title>Careful monitoring for agranulocytosis during carbamazepine treatment</article-title>
          <source>Prim Care Companion J Clin Psychiatry</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>310</fpage>
          <lpage>1</lpage>
          <pub-id pub-id-type="pmid">17235390</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lifshitz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gavrilov</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sofer</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Signs and symptoms of carbamazepine overdose in young children</article-title>
          <source>Pediatr Emerg Care</source>
          <year>2000</year>
          <volume>16</volume>
          <fpage>26</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">10698139</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spiller</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Carlisle</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Status epilepticus after massive carbamazepine overdose</article-title>
          <source>J Toxicol Clin Toxicol</source>
          <year>2002</year>
          <volume>40</volume>
          <fpage>81</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">11990208</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Todorovi&#x107;</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Randelovi&#x107;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Joksovi&#x107;</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jovi&#x107;-Stosi&#x107;</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vucini&#x107;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Glisovi&#x107;</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Carbamazepine cardiotoxicity in acute poisoning</article-title>
          <source>Vojnosanit Pregl</source>
          <year>1993</year>
          <volume>50</volume>
          <fpage>143</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">8351886</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thabet</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Brahmi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Zagdoudi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Amamou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hedhili</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ben</surname>
              <given-names>Salah N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute self poisoning with carbamazepine</article-title>
          <source>Presse Med</source>
          <year>1999</year>
          <volume>28</volume>
          <fpage>955</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">10366929</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mart&#xED;nez</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gonz&#xE1;lez de Etxabarri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ere&#xF1;o</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>L&#xF3;pez</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hinojal</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Teira</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Acute severe hepatic insufficiency caused by carbamazepine</article-title>
          <source>Rev Esp Enferm Dig</source>
          <year>1993</year>
          <volume>84</volume>
          <fpage>124</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">8398372</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belcastro</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>D&#x2019;Egidio</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Striano</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Verrotti</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Metabolic and endocrine effects of valproic acid chronic treatment</article-title>
          <source>Epilepsy Res</source>
          <year>2013</year>
          <volume>107</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">24076030</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
